The evaluation of β-(1 → 3)-nonaglucoside as an anti-Candida albicansimmune response inducer

Synthesis of 3-aminopropyl glycosides of linear β-(1→3)-d-glucooligosaccharides

(2016) Dmitry V. Yashunsky et al.   CARBOHYDRATE RESEARCH

Synthesis and Immunological Studies of Linear Oligosaccharides of β-Glucan As Antigens for Antifungal Vaccine Development

(2015) Guochao Liao et al.   BIOCONJUGATE CHEMISTRY

Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street

(2015) David M. Underhill et al.   IMMUNITY

Whole glucan particles as a vaccine against systemic coccidioidomycosis

(2015) Karl V. Clemons et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Dressed to impress: impact of environmental adaptation on theCandida albicanscell wall

(2015) Rebecca A. Hall   MOLECULAR MICROBIOLOGY

Molecular Interactions of β-(1→3)-Glucans with Their Receptors

(2015) Laurent Legentil et al.   MOLECULES

Synthesis of 3-aminopropyl glycosides of branched β-(1→3)-glucooligosaccharides

(2015) D. V. Yashunsky et al.   RUSSIAN CHEMICAL BULLETIN

Synthetic β-(1→3)-d-glucooligosaccharides: model compounds for the mechanistic study of β-(1→3)-d-glucan bioactivities and design of antifungal vaccines

(2015) Yu. E. Tsvetkov et al.   RUSSIAN CHEMICAL BULLETIN

Adaptive immune responses toCandida albicansinfection

(2015) Jonathan P Richardson et al.   Virulence

Whole glucan particles as a vaccine against murine aspergillosis

(2014) K. V. Clemons et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Deciphering the structure–immunogenicity relationship of anti-Candida glycoconjugate vaccines

(2014) Roberto Adamo et al.   Chemical Science

Synthetically prepared glycooligosaccharides mimickingCandida albicanscell wall glycan antigens - novel tools to study host-pathogen interactions

(2013) Ema Paulovičová et al.   FEMS YEAST RESEARCH

Novel Structural Features inCandida albicansHyphal Glucan Provide a Basis for Differential Innate Immune Recognition of HyphaeVersusYeast

(2013) Douglas W. Lowman et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Theoretical and Experimental Conformational Studies of Oligoglucosides Structurally Related to Fragments of Fungal Cell Wall β-(1→3)-D-Glucan

(2013) Alexey G. Gerbst et al.   JOURNAL OF CARBOHYDRATE CHEMISTRY

The emerging world of the fungal microbiome

(2013) Gary B. Huffnagle et al.   TRENDS IN MICROBIOLOGY

Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy

(2013) Qi-Ying Hu et al.   Chemical Science

Signalling C-Type Lectins in Antimicrobial Immunity

(2013) Rebecca A. Drummond et al.   PLoS Pathogens

Signaling by Myeloid C-Type Lectin Receptors in Immunity and Homeostasis

(2012) David Sancho et al.   Annual Review of Immunology

New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges

(2012) Anna Vecchiarelli et al.   Frontiers in Microbiology

Vaccine and Monoclonal Antibody That Enhance Mouse Resistance to Candidiasis

(2011) Hong Xin et al.   Clinical and Vaccine Immunology

C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature

(2011) M. Kruppa et al.   GLYCOBIOLOGY

Synthesis of Laminarin Fragments and Evaluation of a β-(1,3) Glucan Hexasaccaride-CRM197Conjugate as Vaccine Candidate againstCandida albicans

(2011) Roberto Adamo et al.   JOURNAL OF CARBOHYDRATE CHEMISTRY

Synthesis and Molecular Recognition Studies of the HNK-1 Trisaccharide and Related Oligosaccharides. The Specificity of Monoclonal Anti-HNK-1 Antibodies as Assessed by Surface Plasmon Resonance and STD NMR

(2011) Yury E. Tsvetkov et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

New Insights into the Structure of (1→3,1→6)-β-D-Glucan Side Chains in the Candida glabrata Cell Wall

(2011) Douglas W. Lowman et al.   PLoS One

Potential of anti-Candidaantibodies in immunoprophylaxis

(2010) Jonathan Cabezas et al.   Immunotherapy

Deletion of the Candida albicans histidine kinase gene CHK1 improves recognition by phagocytes through an increased exposure of cell wall  -1,3-glucans

(2010) N. Klippel et al.   MICROBIOLOGY-SGM

Beta-glucan-CRM197 conjugates as candidates antifungal vaccines

(2010) Carla Bromuro et al.   VACCINE

Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia

(2010) A. Brian Mochon et al.   PLoS Pathogens

β-glucan recognition by the innate immune system

(2009) Helen S. Goodridge et al.   IMMUNOLOGICAL REVIEWS

Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence

(2009) Antonella Torosantucci et al.   PLoS One

A β-glucan-conjugate vaccine and anti-β-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique

(2009) Donatella Pietrella et al.   VACCINE

Glucans as Biological Response Modifiers

(2009) M. Novak et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans

(2008) L. Angiolella et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fungal vaccines: real progress from real challenges

(2008) Antonio Cassone   LANCET INFECTIOUS DISEASES

Preparation of glycoconjugates by dialkyl squarate chemistry revisited

(2007) Shu-jie Hou et al.   CARBOHYDRATE RESEARCH

An integrated model of the recognition of Candida albicans by the innate immune system

(2007) Mihai G. Netea et al.   NATURE REVIEWS MICROBIOLOGY